Does adjuvant interferon-alpha for high-risk melanoma provide a worthwhile benefit? A meta-analysis of the randomised trials

K Wheatley, N Ives, B Hancock, M Gore, Lex Eggermont, S Suciu

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)241-252
Number of pages12
JournalCancer Treatment Reviews
Issue number4
Publication statusPublished - 2003

Cite this